Want to see TSE:PSYC full AI Analyst Report?
Top Page
Psyched Wellness
(PSYC)
Select Model
Select Model
Rating:42Neutral
Price Target:
C$0.01
▲(0.00% Upside)
Action:Reiterated
Date:07/30/26
The score is primarily constrained by weak financial performance: negative gross profitability, extremely large operating and net losses relative to revenue, and sustained cash burn. Technicals add pressure as the share price remains below the 50/100/200-day averages, indicating a weak longer-term trend. Valuation is not a clear support factor due to the negative P/E and no dividend yield data.
Positive Factors
No debt on balance sheet
Zero reported debt meaningfully reduces fixed financing obligations and interest burden, giving management flexibility to prioritize operations or raise capital on better terms. This durable structural strength lowers bankruptcy risk while the company addresses cash burn and execution.
Negative Factors
Negative gross profitability
A gross margin near -47% means cost of goods sold materially exceeds revenue, indicating pricing, sourcing or formulation issues. This is a fundamental profitability problem that undermines operating leverage and cannot be solved by cutting SG&A alone; it threatens long-term viable unit economics.
Read all positive and negative factors
Positive Factors
Negative Factors
No debt on balance sheet
Zero reported debt meaningfully reduces fixed financing obligations and interest burden, giving management flexibility to prioritize operations or raise capital on better terms. This durable structural strength lowers bankruptcy risk while the company addresses cash burn and execution.
Read all positive factors
Psyched Wellness (PSYC) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$4.08M
Dividend YieldN/A
Average Volume (3M)81.03K
Price to Earnings (P/E)―
Beta (1Y)-0.38
Revenue Growth65.29%
EPS Growth-1.78%
CountryCA
Employees1,800
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)-0.02
Shares Outstanding407,715,850
10 Day Avg. Volume36,477
30 Day Avg. Volume81,030
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)1.86
Price to Sales (P/S)12.22
P/FCF Ratio-1.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Psyched Wellness Business Overview & Revenue Model
Company Description
Psyched Wellness Ltd. operates as a health supplements enterprise, specializing in the production and distribution of artisanal medicinal mushrooms and their associated consumer packaged goods. A prominent offering is their Amanita Muscaria Tinctu...
How the Company Makes Money
Psyched Wellness primarily makes money by commercializing and selling Amanita muscaria–derived wellness products under its consumer brands (including Calm). Revenue is generated through product sales (e.g., direct-to-consumer e-commerce and other ...
Psyched Wellness Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
46
Neutral
Cash Flow
20
Very Negative
| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 746.40K | 472.30K | 623.16K | 321.10K | 14.27K | 0.00 |
| Gross Profit | -618.28K | 189.79K | 241.89K | 155.71K | 7.54K | 0.00 |
| EBITDA | -5.91M | -5.08M | -4.52M | -3.32M | -4.29M | -65.14K |
| Net Income | -5.37M | -5.04M | -4.26M | -3.43M | -4.30M | -4.50M |
Balance Sheet | ||||||
| Total Assets | 2.04M | 3.75M | 7.89M | 7.34M | 3.31M | 6.38M |
| Cash, Cash Equivalents and Short-Term Investments | 605.05K | 2.25M | 6.36M | 6.13M | 2.57M | 5.53M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 346.41K | 644.82K | 449.33K | 303.56K | 198.07K | 178.15K |
| Stockholders Equity | 1.69M | 3.10M | 7.44M | 7.03M | 3.11M | 6.20M |
Cash Flow | ||||||
| Free Cash Flow | -4.41M | -4.05M | -3.11M | -3.11M | -3.18M | -3.04M |
| Operating Cash Flow | -4.42M | -4.05M | -3.10M | -3.03M | -3.09M | -3.01M |
| Investing Cash Flow | 2.52K | 0.00 | -2.78K | -44.84K | 126.99K | -28.58K |
| Financing Cash Flow | 756.61K | 0.00 | 3.39M | 6.64M | 0.00 | 6.51M |
Psyched Wellness Technical Analysis
Negative
0.01
Price Trends
0.01
Negative
0.01
Negative
0.01
Negative
Market Momentum
>-0.01
Negative
45.95
Neutral
100.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:PSYC, the sentiment is Negative. The current price of 0.01 is above the 20-day moving average (MA) of <0.01, below the 50-day MA of 0.01, and below the 200-day MA of 0.01, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 45.95 is Neutral, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:PSYC.
Psyched Wellness Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | C$1.72B | 23.49 | 15.25% | 2.25% | 12.52% | 37.38% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
44 Neutral | C$231.27M | -17.79 | -366.67% | ― | 119.70% | -368.06% | |
42 Neutral | C$4.08M | -0.58 | -70.53% | ― | 65.29% | -1.78% | |
41 Neutral | C$690.59K | -0.16 | -345.48% | ― | 3288.96% | 50.66% |
* Consumer Defensive Sector Average
TSE:PSYC
Psyched Wellness
0.01
-0.01
-50.00%
TSE:BITE
Blender Bites
0.15
0.00
0.00%
TSE:JWEL
Jamieson Wellness Inc
41.50
4.96
13.58%
TSE:HBFG
Happy Belly Food Group
1.57
0.50
46.73%
TSE:MOOO.X
Happy Supplements Inc.
0.35
-0.03
-7.89%
TSE:CULT
Cult Food Science Corp.
0.28
-0.22
-45.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.